Spectrum Medical Group is dedicated to improving the quality of both healthcare and patient safety. Quality continues to be a strategic focus of our Board of Directors. The Board's strategic initiatives include the following goals:
Spectrum's quality efforts are driven by our physicians. The company supports the investment of physician resources in building and improving infrastructure and systems implemented at our hospitals and sites of service.
Each of our specialties at Spectrum has a comprehensive quality program. The efforts of our quality programs demonstrate meaningful progress in error reduction, enhanced patient safety, and improved outcomes.
Choosing Wisely® is an initiative of the ABIM Foundation to help physicians and patients engage in conversations about the overuse of tests and procedures and support physician efforts to assist patients in making smart and effective care choices. As part of the campaign, participating medical specialty societies have identified commonly used tests or procedures in their field that maybe overused. To date, 60 specialty societies have identified over 220 tests or procedures that may be unnecessary or could cause harm.
“The physicians in our division embraced these recommendations well prior to the inception of the Choosing Wisely Campaign, ” stated Celine Godin, M.D./M.P.H, managing director of Spectrum’s Radiation Oncology Division. “Choosing Wisely gives physicians the tools they need to talk with patients about appropriate care choices. These important conversations ensure our patients receive the right care, at the right time, and in the right way.” Spectrum has led efforts to promote the Choosing Wisely recommendations throughout each of our divisions. A few of these evidence-based recommendations include:
Don’t perform low-risk HPV testing (American Society for Clinical Pathology)
Don’t perform electroencephalography (EEG) for headaches (American Academy of Neurology)
Avoid admission or preoperative chest x-rays for ambulatory patients with unremarkable history and physical exam (American College of Radiology)
Don’t obtain baseline laboratory studies in patients without significant systemic disease (ASA I or II) undergoing low-risk surgery (American Society of Anesthesiologists)
Don’t initiate management of low-risk prostate cancer without discussing active surveillance (American College of Radiation Oncology)